Structure Therapeutics

Structure Therapeutics

Specializes in the discovery and development of drugs against a type of targets called GPCR.

HQ location
South San Francisco, United States
Launch date
Employees
Market cap
$1.1b
Enterprise value
$316m
Share price
$19.14 GPCR
Authorizing premium user...